Why This Matters for Your Career
Bristol Myers Squibb is hiring 10 roles related to this product
HALOPERIDOL (haloperidol lactate) by Bristol Myers Squibb is clinical pharmacology haloperidol is an antipsychotic. Approved for schizophrenia. First approved in 1987.
CLINICAL PHARMACOLOGY Haloperidol is an antipsychotic. The mechanism of action of haloperidol for the treatment of schizophrenia is unclear. However, its efficacy could be mediated through its activity as an antagonist at central dopamine type 2 receptors. Haloperidol also binds to alpha-1…
IM Olanzapine Versus Haloperidol or Midazolam
Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
Pilot Study of Haloperidol to Treat Critical Illness Delirium
Worked on HALOPERIDOL at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bristol Myers Squibb is hiring 10 roles related to this product